ArticleAnnals of hematology2025

Inotuzumab therapy resulted in molecular remission of relapsed/resistant B-cell acute lymphoblastic leukemia with BCR::ABL1 Lys404Glu mutation.

Krzysztof Lewandowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.